-
1 Comment
Guangzhou Boji Medical & Biotechnological Co., Ltd is currently in a long term uptrend where the price is trading 0.5% above its 200 day moving average.
From a valuation standpoint, the stock is 3.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.0.
Guangzhou Boji Medical & Biotechnological Co., Ltd's total revenue rose by 37.2% to $67M since the same quarter in the previous year.
Its net income has increased by 185.6% to $8M since the same quarter in the previous year.
Finally, its free cash flow grew by 101.4% to $176K since the same quarter in the previous year.
Based on the above factors, Guangzhou Boji Medical & Biotechnological Co., Ltd gets an overall score of 4/5.
CurrencyCode | CNY |
---|---|
ISIN | CNE100001Y00 |
Sector | Healthcare |
Industry | Biotechnology |
Exchange | SHE |
Market Cap | 3B |
---|---|
PE Ratio | 206.75 |
Target Price | 11.74 |
Dividend Yield | 0.1% |
Beta | 0.14 |
Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, product test, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of phased technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300404.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025